Salvia miltiorrhiza-containing Chinese patent medicine for treating cardia-cerebrovascular diseases and preparation process of Chinese patent medicine preparation

Abstract

The invention discloses a red sage root-containing Chinese patent medicine for treating cardia-cerebrovascular diseases and a preparation process of a Chinese patent medicine preparation, the Chinese patent medicine preparation comprises the following components: 45 parts of red sage root, 5 parts of borneol, 23 parts of Poria cocos, 18 parts of red peony root, 13 parts of amber, 18 parts of licorice, 13 parts of sargentgloryvine stem, 5 parts of phaseolus calcaratus and 5 parts of auxiliary materials, and the preparation process comprises the following steps: cleaning the raw materials to eliminate impurities, removing non-medication parts, and drying to obtain the red sage root-containing Chinese patent medicine for treating cardia-cerebrovascular diseases. Then cleaning, soaking after cleaning, and steaming with boiling water; cutting the treated raw materials into slices; carrying out microwave sterilization and drying on the flaky raw materials; mixing and heating the sterilized raw materials and the auxiliary materials; chopping the processed raw materials, adding the chopped raw materials into an extraction tank, adding ethanol twice the weight of the chopped raw materials, decocting for 30 minutes, carrying out reflux extraction, extracting filtrate, and concentrating; cooling the concentrated solution, adding ethanol twice the weight of the concentrated solution, fully stirring, and standing at normal temperature for 20 hours; centrifuging the supernate, and then cooling and filtering at normal temperature. The preparation technology of the Chinese patent medicine and the preparation is easy to obtain raw materials, and the obtained preparation is excellent in treatment effect and small in toxic and side effect.

Description

technical field [0001] The invention relates to the technical field of Chinese patent medicines, in particular to a Chinese patent medicine containing Salvia miltiorrhiza for treating cardiovascular and cerebrovascular diseases and a preparation process of a Chinese patent medicine preparation. Background technique [0002] The main causes of cardiovascular and cerebrovascular diseases are hyperlipidemia, hypertension, hyperglycemia and hyperviscosity. At present, with the aging of the population and the improvement of living standards, my country is entering the "window period" of cardiovascular disease outbreaks, and has a huge consumer group of cardiovascular drugs. [0003] The main medicinal components of Salvia miltiorrhiza are tanshinone ≥ 0.25%, salvianolic acid B ≥ 3%, and the content of tanshinone in Fangcheng Salvia (Yudanshen) is stable at about 0.6% after testing, which is more than twice the standard set by the National Pharmacopoeia; salvianolic acid B The co...

AI Technical Summary

Problems solved by technology

[0004] At present, most of the cardiovascular and cerebrovascular drugs containing salvia miltiorrhiza contain more expensive Chinese medicinal materials, such as ginseng, bezoar, musk, etc., as well as some in-demand medicinal materials such as Panax notoginseng. The improvement has limited the preparation and application of drugs; in addition, the drugs obtained by the existing preparation process also have problems such as poor therapeutic effect and large toxic and side effects.